Suministro del medicamento CEFIDEROCOL (DOE) para todas las organizaciones de servicios de Osakidetza y centros vinculados.
TED · 578005-2026Award notice · modificationawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Dirección General - Osakidetza in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ABBOTT LABORATORIES, S.A. | 2 | €19,474,073 | 2026-07-27 |
| Novartis Farmaceutica S.A. | 2 | €6,432,568 | 2026-08-19 |
| ABBVIE SPAIN, S.L.U | 2 | €2,570,400 | 2026-07-15 |
| SANOFI-AVENTIS, S.A. | 2 | €1,421,360 | 2026-07-27 |
| LABORATORIOS FARMACEUTICOS ROVI, S.A. | 2 | €283,349 | 2026-07-02 |
Full buyer profile: what Dirección General - Osakidetza buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
CEFIDEROCOL Principio activo: CEFIDEROCOL (DOE) Cantidad de principio activo: 1G Forma farmacéutica: vial Condiciones de envasado: dosis unitaria
Similar tenders
Closest by meaning — across languages, via embeddings.